VCI Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
VCI Wealth Management's ABBV Position: Q1 2026 in Review
VCI Wealth Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 12,008 shares — an estimated $2.74M sold.
VCI Wealth Management first reported a position in ABBV in Q1 2025 and held it in 3 quarters. The position peaked at $2.74M in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- VCI Wealth Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- VCI Wealth Management sold 12,008 AbbVie shares in Q1 2026, an estimated $2.74M.
- VCI Wealth Management first reported a position in AbbVie in Q1 2025 and held it in 3 quarters.
- VCI Wealth Management's AbbVie position peaked at $2.74M in Q4 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on VCI Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.